Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15–60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials

Overview of attention for article published in Annals of Hematology, June 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 636 followers.

Baron, F.-Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML... https://t.co/bcxYiFiyne

Reply Repost Favourite